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Objective: To determine frequency and pattern of antibiotic prescription in COVID-19 patients presenting in 
DHQ teaching hospital, Sahiwal.  
Material and Methods: This observational cross-sectional prospective study was conducted from 1st June 2020 to 
31st March 2021 in patients admitted in COVID isolation facility of DHQ Teaching hospital, Sahiwal with 
confirmed COVID-19 infection. Patients of all ages and of both genders were included. Data was collected by a 
pre-designed proforma. Data included patient’s age, gender, co-morbid conditions, type and duration of 
antibiotic use, and details of prescribing physicians. Descriptive statistics were applied to determine frequency 
and percentages of variables. 
Results: Out of 800 participants, 543 (67.8%) were males, and the remaining 257  (32.1%) were females. 
Majority 328 (41%) of patients belonged to age group 40-60 years. 639 (79.8%) patients had co-morbidities. 
Diabetes mellitus was the most common co-morbid condition 248 (31%). Antibiotics were prescribed to all 
patients 800 (100%) before admission to the COVID Isolation facility. The majority of patients 348 (43.5%) had 
used antibiotics for 3-7 days before admission. Macrolides class was the most commonly prescribed antibiotic 417 
(52.1%). General practitioners had more tendency to prescribe antibiotics 509 (64%) as compared to medical 
specialists 212 (26.5%) and pulmonologists 79 (9.8%). 
Conclusion: Antibiotic stewardship needs to be improved in COVID-19 patients and prescription should be 
evidence-based aided by laboratory tests. Development of local guidelines for judicious antibiotic prescription in 
COVID-19 will help in preventing antibiotic resistance. 
Keywords: Antibiotics, antibiotic resistance, COVID-19, drug prescription, SARS-CoV-2. 
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Introduction 
 
After the very fortunate discovery of penicillin, the 
treatment of bacterial infections stepped into a new 
era. This revolution had a huge impact on the world 
during world war when hundreds of thousands of 
soldiers got relief from infected wounds and the later 
impact was passed on to the post-war era. With the 
discovery of penicillin, there was huge research in 
pharmacology and microbiology of microscopic 
organisms and their drug formulations. As a result, 
new antibiotics with better coverage and better 
efficacy were formulated and marketed.1 Antibiotic 
have traveled very far since the discovery of penicillin 
in a small duration of time with the introduction of 
many new classes and generations. Today these drugs 
have significantly reduced postoperative 
complications and cured millions of patients 
worldwide with their magical influence.2 The 
introduction of broad-spectrum antibiotics is a key 
step in this regard. Some of these antibiotic groups 
include penicillins, macrolides, fluoroquinolones, and 
carbapenem groups.3 
Due to magical improvement in patient’s symptoms 
suffering from bacterial infections, antibiotic use 
spread dramatically all over the world including in 
developing countries. Unfortunately with excessive 
use, the phenomenon of antibiotic resistance has 
become a menace now.3,4 The causes of antibiotic 
resistance are multifactorial including over the counter 
sale in many countries, the wrong choice of antibiotics 
for the management of infections, use of antibiotics for 
less than the recommended time, use of antibiotics 
without culture and sensitivity, and use of antibiotics 
in infections caused by other microorganisms 
including viruses, parasites, and fungi.5,6 
COVID-19 Pandemic spread like wildfire after first 
cases reported in Wuhan China. Currently, it has 
affected more than 223 countries of the world with 
drastic effects on the world economy and social lives 
of individuals. Unfortunately, the signs and symptoms 
of COVID-19 share similarities with signs and 
symptoms of infections caused by many other 
microorganisms including bacteria, parasites, and 
fungi.7,8 Pakistani population are very much 
dependent on general practitioners(GPs) and over the 
counter purchase of drugs from medical stores and 
pharmacies. From the start of the COVID-19 
pandemic, there was a huge social stigma attached to 
COVID-19 cases due to fear in the masses and strict 
isolation and burial policies of the government. Due to 
these factors COVID-19 has been mistakenly 
diagnosed as enteric fever and other bacterial diseases 
due to lack of knowledge of GPs and to satisfy patients 
psychologically. As a result of these factors, a 
significant number of COVID-19 cases have already 
received antibiotics for COVID treatment upon their 
arrival in tertiary care hospitals. Similarly, there was a 
substantial non-evidence-based prescription of various 
drugs during COVID-19 including 
Hydroxychloroquine, Azithromycin, and Vibramycin 
to COVID cases worldwide including Pakistan.9 Many 
antibiotics were “tried” on COVID cases and led to the 
danger of emerging antibiotic resistance.  
Due to the increasing number of COVID-19 cases the 
use of oral or intravenous antibiotics was more and 
more evident. This study was planned to encompass 
the brutal use of antibiotics and to predict possible 
future antibiotic resistance which treating physicians 
may encounter in the management of various endemic 
bacterial diseases like enteric fever and UTI in a post-
COVID era in Pakistan. This study is aimed to create 
awareness about the meticulous use of precious 
antibiotics to minimize post-COVID antibiotic 
resistance. 
 
Materials and Methods 
 
This observational cross-sectional prospective study 
was conducted in patients admitted to DHQ Teaching 
hospital Sahiwal with COVID-19 infection from 1st 
June 2020 to 31st March 2021. The study was approved 
by the Institutional review board of Sahiwal Medical 
College, Sahiwal via letter no 62/DME/SLMC/SWL.  
Data was collected from 800 symptomatic patients of 
COVID-19 confirmed by nasopharyngeal swab PCR 
presenting to COVID isolation facility during the 
period of 1st June 2020 to 31st March 2020. Study 
subjects were included by convenient non-probability 
sampling. COVID-19 cases of all severity classes and 
any age and gender having suggestive symptoms 
(Fever, cough, body aches, shortness of breath, 
diarrhea) with positive PCR report of Nasopharyngeal 
swab for SARS-Cov-2 PCR were included. All patients 
who had negative PCR with or without symptoms 
were excluded. Data was collected on a predesigned 
proforma after taking informed consent. Data included 
demographic details, co-morbid conditions, smoking 
status, type and duration of antibiotic use, route of 
antibiotic administration, and details of prescribing 
physicians. Data analysis was done by using SPSS 24. 
Data were arranged in terms of gender, age groups, 
and admission status. The frequency of use of 
antibiotics along with the frequency of use of various 
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drug groups, route of administration, and prescribing 
doctor status was calculated using frequency tables. 
Descriptive statistics were applied to determine the 




Antibiotics were prescribed and used by all 800 (100%) 
confirmed cases of COVID-19. The majority of the 
patients were males 543(67.8%) while 257 were 
females (32.1%). Most patients 328(41%) belonged to 
the 40-60 years age group followed by the above 60 
age group 243(30.3%), 20-40 years age group 
217(27.1%), and below 20 years 12(1.5%). (Figure 1) 
 
Figure 1: Frequency distribution of age groups 
 
In the majority of cases, 509(63.6%) antibiotics were 
prescribed by General practitioners followed by 
medical specialists 212(26.5%) and pulmonologists 
79(9.8%). (Figure 2) 
 
Figure 2: Frequency distribution of prescribing 
doctors 
 
Comorbid conditions were present in 639(79.8%) 
patients. 128(20%) patients had more than one 
comorbidity. Diabetes was the most common co-
morbidity followed by hypertension. (Table 1) 
Table 1: Frequency Distribution of Comorbidities. 
(N=800) 
Characteristics n (%) 
Smokers 118 (14.7) 
Co-Morbidities 639 (79.8) 
Diabetes 248 (31.0) 
Hypertension 157 (19.6) 
Ischemic Heart Disease 87 (10.8) 
Chronic Kidney Disease 19  (2.0) 




As far as the route of drug administration was 
concerned 358(44.7%) patients used oral antibiotics 
while 293(36.6%) used intravenous antibiotics. 
149(18.6%) patients received both oral and intravenous 
antibiotics. Macrolides were the most commonly 
prescribed group of antibiotics 417(52.1%) followed by 
cephalosporins 118(14.7%), Fluoroquinolones 78(9.7%), 
Carbapenems 59(7.3%), and tetracyclines 26(3.2%). 
(Table 2) 
 
Table 2: Antibiotic Prescription pattern (N=800) 
Variable Characteristics n(%) 
Status of antibiotic use Yes 800(100) 
No 0(0) 
Route of administration Both Oral and IV 149(18.6) 
IV 293(36.6) 
Oral 358(44.7) 





More than one 
Antibiotics 
102(12.7) 
Duration of antibiotic 
use at presentation 
Less than 3 days 172(21.5) 
3 to 7 days 348(43.5) 




Pakistan is a developing country and it has a high 
practice of inappropriate antibiotic use. The main 
factors behind this are lack of education, lack of 
awareness, high consultation fees of consultants, and 
over-the-counter sale of antibiotics.8,10 These all factors 
led to inappropriate use of antibiotics in the COVID-19 
pandemic as well. There has been an increase in 
community use of antibiotics during COVID-19.9 The 
role of antibiotics in the management of COVID-19 is 
not proven, although antibiotics may be used later in 
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the course of disease in case of secondary bacterial 
infection. The use of inappropriate antibiotics may 
result in the emergence of antibiotic resistance and it 
has no impact on patient mortality.11 Lack of proper 
antibiotic stewardship and irrational use of these 
useful antibiotics may lose their impact due to the 
ever-increasing challenge of drug-resistant enteric 
fever, urinary tract infection, and drug-resistant 
tuberculosis.12 There should be proper stewardship of 
antibiotics in the management of COVID-19 cases and 
bacterial secondary infection should be detected by 
use of clinical and laboratory parameters including 
increased levels of serum pro-calcitonin and a second 
increase in CRP Quantitative levels after getting 
normal during disease treatment.12 
Our study showed 100% prescription of antibiotics in 
the initial stage of COVID-19 infection which is per 
earlier studies showing brutal use of empiric 
antibiotics from 71-100% in COVID-19 patients.9,13-17 
There is a common practice of using antibiotics for the 
management of viral respiratory tract diseases due to 
overlapping symptoms between bacterial and viral 
respiratory tract infections especially by general 
practitioners in previous studies.9,14 This fact is shown 
in our study where a high percentage of patients 
received antibiotics from general practitioners (63.6%). 
Patients were prescribed oral and intravenous 
antibiotics which is a common practice in Pakistan due 
to the over-the-counter availability of antibiotics.18 Due 
to the availability of over-the-counter antibiotics in 
Pakistan and many other developing countries, there 
is a risk of anti-microbial resistance in the world.19 
Many developed countries have banned the use of 
antibiotics over the counter. Unlike many other studies 
which showed increased use of quinolones and 
carbapenems in COVID-19 treatment we found 
Macrolides to be the most common group of 
antibiotics used followed by cephalosporins and 
carbapenems.16,20 Many antibiotics used for the 
management of COVID-19 have a role in enteric fever 
management. Extensive irrational use of macrolides 
group of antibiotics is alarming as it has a vital role in 
the management of enteric fever and its irrational use 
can worsen already increasing drug-resistant enteric 
fever in Pakistan.21 According to WHO Pakistan is a 
country with a risk of extensive drug-resistant enteric 
fever and many developed countries have been issued 
travel precautions for travel in Pakistan. Another 
group of antibiotics fluoroquinolones has also been 
prescribed according to our study. Pakistan has a high 
percentage of Fluoroquinolone resistance. 
Fluoroquinolones have a major role in the 
management of community-acquired pneumonia and 
tuberculosis. The new WHO guidelines for the 
management of multidrug-resistant TB have the 
pivotal role of fluoroquinolones in them and the use of 
these groups of antibiotics can lead to extensive 
fluoroquinolone resistance which can lead to difficulty 
in the management of multidrug-resistant 
tuberculosis.22 Similarly, macrolide and 
fluoroquinolone resistance is already documented in 
H-pylori isolates in Pakistan and any further irrational 
prescription can lead to an increase in resistance to H-
pylori.23 Another disease with threats of the emergence 
of resistance in antibiotics during its management is 
urinary tract infection. COVID antibiotics' 
inappropriate use can worsen this situation as well.24 
Use of antibiotics have also caused more cost to 
COVID management while trials show very cost-
effective drugs for management of COVID-19 with the 




Due to limitations of resources, samples for 
antimicrobial culture and sensitivity could not be 
collected to assess the need for antibiotics and the 
resistance pattern of antibiotics. Similarly, there was 




Poor antibiotic stewardship can lead to aggravation of 
antibiotic resistance in a developing country like 
Pakistan. Post-COVID Pakistan may witness a tsunami 
of antibiotic resistance especially for antibiotics used in 
the management of enteric fever, MDR TB, H-pylori 
eradication, and UTI. This may lead to catastrophe in 
the management of the above-mentioned diseases. It is 
recommended to follow the antibiotic stewardship 
program and the use of antibiotics in COVID-19 must 
be decided after evaluating the patient’s clinical 
scenario and results of biochemical tests like serum 
Pro-calcitonin and CRP Quantitative to avoid 
antibiotic resistance. The development of local 
guidelines for judicious antibiotic prescription in 
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